KR20170050062A - Composition for Beverage and Cosmetics Containing Asiaticoside Madecassoside Asiatic acid Madecasic acid Extracted from Centella Asiatica Manufacturing Method Thereof - Google Patents
Composition for Beverage and Cosmetics Containing Asiaticoside Madecassoside Asiatic acid Madecasic acid Extracted from Centella Asiatica Manufacturing Method Thereof Download PDFInfo
- Publication number
- KR20170050062A KR20170050062A KR1020150151106A KR20150151106A KR20170050062A KR 20170050062 A KR20170050062 A KR 20170050062A KR 1020150151106 A KR1020150151106 A KR 1020150151106A KR 20150151106 A KR20150151106 A KR 20150151106A KR 20170050062 A KR20170050062 A KR 20170050062A
- Authority
- KR
- South Korea
- Prior art keywords
- acid
- composition
- cosmetic
- mixture
- beverage
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 154
- 239000002253 acid Substances 0.000 title claims abstract description 85
- 239000002537 cosmetic Substances 0.000 title claims abstract description 52
- 235000013361 beverage Nutrition 0.000 title claims abstract description 32
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 10
- 244000146462 Centella asiatica Species 0.000 title claims description 3
- 235000004032 Centella asiatica Nutrition 0.000 title claims description 3
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 title abstract description 26
- BNMGUJRJUUDLHW-HCZMHFOYSA-N Madecassoside Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(C[C@@H](O)[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O BNMGUJRJUUDLHW-HCZMHFOYSA-N 0.000 title abstract description 17
- BNMGUJRJUUDLHW-HLUHVYOBSA-N Madecassoside Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5[C@H](O)C[C@@]34C)[C@@H]2[C@H]1C)C(=O)O[C@@H]6O[C@H](CO[C@@H]7O[C@H](CO)[C@@H](O[C@@H]8O[C@H](C)[C@H](O)[C@@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@@H](O)[C@H](O)[C@H]6O BNMGUJRJUUDLHW-HLUHVYOBSA-N 0.000 title abstract description 17
- 229940090813 madecassoside Drugs 0.000 title abstract description 17
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 title abstract description 9
- 229940022757 asiaticoside Drugs 0.000 title abstract description 9
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 title abstract description 9
- 229940011658 asiatic acid Drugs 0.000 title abstract description 7
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 title abstract description 7
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 title abstract description 7
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 title abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 35
- 230000000694 effects Effects 0.000 claims abstract description 29
- 230000029663 wound healing Effects 0.000 claims abstract description 25
- 229930182470 glycoside Natural products 0.000 claims abstract description 16
- 150000002338 glycosides Chemical class 0.000 claims abstract description 15
- 230000008929 regeneration Effects 0.000 claims abstract description 15
- 238000011069 regeneration method Methods 0.000 claims abstract description 15
- 239000006071 cream Substances 0.000 claims description 27
- 239000000344 soap Substances 0.000 claims description 14
- 239000006210 lotion Substances 0.000 claims description 12
- -1 packs Substances 0.000 claims description 10
- 239000002453 shampoo Substances 0.000 claims description 8
- 208000017520 skin disease Diseases 0.000 claims description 7
- 230000006806 disease prevention Effects 0.000 claims description 5
- STNJBCKSHOAVAJ-UHFFFAOYSA-N Methacrolein Chemical compound CC(=C)C=O STNJBCKSHOAVAJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 230000003472 neutralizing effect Effects 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 229940059958 centella asiatica extract Drugs 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims 3
- 230000000475 sunscreen effect Effects 0.000 claims 1
- 239000000516 sunscreening agent Substances 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 12
- 230000003020 moisturizing effect Effects 0.000 abstract description 10
- 238000002156 mixing Methods 0.000 abstract description 7
- 239000000413 hydrolysate Substances 0.000 abstract 2
- 239000003513 alkali Substances 0.000 abstract 1
- 239000000284 extract Substances 0.000 description 23
- 238000012360 testing method Methods 0.000 description 20
- 235000019441 ethanol Nutrition 0.000 description 17
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 230000037303 wrinkles Effects 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 13
- 235000016709 nutrition Nutrition 0.000 description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 241000258920 Chilopoda Species 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 210000003491 skin Anatomy 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 230000006872 improvement Effects 0.000 description 9
- 230000036560 skin regeneration Effects 0.000 description 9
- 235000013336 milk Nutrition 0.000 description 8
- 239000008267 milk Substances 0.000 description 8
- 210000004080 milk Anatomy 0.000 description 8
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 7
- 230000037394 skin elasticity Effects 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- 235000020510 functional beverage Nutrition 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- 210000004927 skin cell Anatomy 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- 102000004889 Interleukin-6 Human genes 0.000 description 4
- 108090001005 Interleukin-6 Proteins 0.000 description 4
- 229920001214 Polysorbate 60 Polymers 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 4
- 239000002480 mineral oil Substances 0.000 description 4
- 235000010446 mineral oil Nutrition 0.000 description 4
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 4
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 4
- 229940113124 polysorbate 60 Drugs 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 4
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 4
- 229960003415 propylparaben Drugs 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 3
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000006143 cell culture medium Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 3
- 229940075529 glyceryl stearate Drugs 0.000 description 3
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 3
- 210000002510 keratinocyte Anatomy 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 210000004761 scalp Anatomy 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 3
- 229960002920 sorbitol Drugs 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 2
- 240000000912 Macadamia tetraphylla Species 0.000 description 2
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 235000002789 Panax ginseng Nutrition 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 108010009736 Protein Hydrolysates Proteins 0.000 description 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
- 238000011529 RT qPCR Methods 0.000 description 2
- 241001115903 Raphus cucullatus Species 0.000 description 2
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 230000003556 anti-epileptic effect Effects 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000008278 cosmetic cream Substances 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 235000012907 honey Nutrition 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 230000003301 hydrolyzing effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000010466 nut oil Substances 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229950011392 sorbitan stearate Drugs 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- LCVHZNSIAYNAGX-UHFFFAOYSA-N 2-ethylhexyl 3,5,5-trimethylhexanoate Chemical compound CCCCC(CC)COC(=O)CC(C)CC(C)(C)C LCVHZNSIAYNAGX-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- GADSJKKDLMALGL-UHFFFAOYSA-N 2-propylbenzoic acid Chemical compound CCCC1=CC=CC=C1C(O)=O GADSJKKDLMALGL-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 210000003771 C cell Anatomy 0.000 description 1
- DHFUFHYLYSCIJY-WSGIOKLISA-N CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O Chemical compound CCCCCCCCCCCCCCCCCCCCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DHFUFHYLYSCIJY-WSGIOKLISA-N 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 241000931705 Cicada Species 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000008070 Interferon-gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 240000005382 Saccharum spontaneum Species 0.000 description 1
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 102000004338 Transferrin Human genes 0.000 description 1
- 108090000901 Transferrin Proteins 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 244000250129 Trigonella foenum graecum Species 0.000 description 1
- 235000001484 Trigonella foenum graecum Nutrition 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229940079894 benzophenone-9 Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- FYBYQXQHBHTWLP-UHFFFAOYSA-N bis(silyloxysilyloxy)silane Chemical compound [SiH3]O[SiH2]O[SiH2]O[SiH2]O[SiH3] FYBYQXQHBHTWLP-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 229940099417 ceramide 2 Drugs 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000036570 collagen biosynthesis Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- QDCHWIWENYCPIL-UHFFFAOYSA-L disodium;4-hydroxy-5-(2-hydroxy-4-methoxy-5-sulfonatobenzoyl)-2-methoxybenzenesulfonate Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC(S([O-])(=O)=O)=C(OC)C=C1O QDCHWIWENYCPIL-UHFFFAOYSA-L 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 229940100549 ethylhexyl isononanoate Drugs 0.000 description 1
- 238000010195 expression analysis Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 239000004083 gastrointestinal agent Substances 0.000 description 1
- 229940127227 gastrointestinal drug Drugs 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 238000003633 gene expression assay Methods 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229940116978 human epidermal growth factor Drugs 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229960003130 interferon gamma Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 238000013532 laser treatment Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000002953 phosphate buffered saline Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000001817 pituitary effect Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229940068977 polysorbate 20 Drugs 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- GHBFNMLVSPCDGN-UHFFFAOYSA-N rac-1-monooctanoylglycerol Chemical compound CCCCCCCC(=O)OCC(O)CO GHBFNMLVSPCDGN-UHFFFAOYSA-N 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 210000001626 skin fibroblast Anatomy 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229950004959 sorbitan oleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000012581 transferrin Substances 0.000 description 1
- 235000001019 trigonella foenum-graecum Nutrition 0.000 description 1
- OFLNOEMLSXBOFY-UHFFFAOYSA-K trisodium;dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([S-])=S OFLNOEMLSXBOFY-UHFFFAOYSA-K 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/60—Sugars, e.g. mono-, di-, tri-, tetra-saccharides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cosmetics (AREA)
Abstract
Description
The present invention relates to a beverage and cosmetic composition comprising Asian ticoside, madecasoside, asialic acid and methacaric acid isolated from a centrum, and a method for producing the same. More particularly, the present invention relates to a method for producing a glycoside compound, which comprises reacting a fenugreek with an alcohol and filtering the mixture to thereby obtain a mixture of glycosidic compounds such as Asiaticoside and Madecassoside, Crystallizing the mixture to obtain an Asian ticoside; and dissolving the glycoside asidoside and the mixture of madecassoside in alcohol, reacting with a strong base, neutralizing with strong acid, and concentrating and drying to obtain a hydrolyzate, asiatic acid, And Madecasic acid; and a step of mixing the above glycosides such as Asian ticoside and madecassoside or hydrolyzate, asialic acid and methacaric acid, alone or in admixture of two or more with cosmetic or beverage ingredients, To form a composition or beverage composition.
The present invention is to provide a beverage composition or a cosmetic composition by using alone or in combination of an Asian ticoside and a madecassoside or an asialic acid and a madeca acid to provide effects such as moisturizing effect, wound healing and cell regeneration.
Centella asiatica is a perennial plant called the tiger grass and clam, which is common in the mountains and fields of southern islands of the peninsula. It has been widely used for skin diseases due to burns, wound healing and protection. The total amount of Asian ticoside and madecasoside is 2 ~ 8% depending on the growing area. When they are extracted with ethanol, Asian ticoside and Asian acid are obtained. Wound healing, and cell regeneration. The pharmacological mechanism is known to have an effect of promoting collagen biosynthesis in skin cells.
As a related art related to the present invention, Korean Patent Laid-Open Publication No. 10-2015-0050310 is a composition for improving skin condition containing a mixed extract of Cheongho, milt leaf, Korean green pepper and green tea or a fraction thereof as an active ingredient. Korean Patent Laid-Open No. 10-2003-0024932 is a dried product of Kunchuk extract containing 0.0001 to 10.0% by weight, based on the total dry weight of the cosmetic composition, using the active ingredient, Asian ticoside. Korean Patent No. 10-0641302 is a cosmetic composition for improving skin wrinkles containing Asian ticoside and Asian acid at a ratio of 1.5 to 2.5: 1. Korean Patent No. 10-0511944 is a cosmetic composition comprising a multilayer liposome in which Asian ticoside as an active ingredient for improving wrinkles is captured. These prior arts have focused on moisturizing effect or wrinkle-improving effect as a composition of a cosmetic composition which utilizes a mixture of Asian ticoside alone or with an asialic acid. However, the present invention relates to a cosmetic composition containing a further addition of the compound of the formula, that is, a cosmetic cream, a shampoo, a soap, etc. to improve skin wounds and improve the cell regeneration effect. Focused on improved differentiated effects.
The present invention also provides a functional drink using a single ingredient or a mixture of Asian ticoside, madecaside, asialic acid, and methacaric acid, and has an anti-epileptic function utilizing cell regeneration effect. Until now, no patent has been developed as a functional drink And the present invention is unique.
The chemical structures of the Asian ticoside, the madecaside, the asialic acid and the methacaric acid mentioned in the present invention are as shown in the following chemical formulas (1) to (4). The following formula 1 is an asymmetric acid, the following formula 1 is asiaticoside, the following formula 2 is a madecosaide, the following formula 3 is an asialic acid, and the following formula 4 is a magetic acid.
It is an object of the present invention to provide a cosmetic composition that is more effective for skin moisturizing and wrinkle-improving as well as wound healing and cell regeneration. The present invention also provides a functional beverage having wound healing and cell regeneration effects, as well as a skin improving effect, by using a centilla extract or a hydrolyzate thereof singly or in combination.
In the prior art, when extracts of the clover are extracted with ethanol, only the Asian ticoside and the Asian acid are obtained, and they have been used as a cosmetic composition for moisturizing or improving wrinkles by using them alone or in a mixture. However, since there is no technique for separating madecasoside and methacaric acid separately, the effect of improving skin beauty is deteriorated because they are not included, and consumers who do not use such cosmetics have a disadvantage that it is difficult to expect a skin cosmetic improvement effect of centilla extract.
The present invention relates to a method for producing an Asian ticoside, which comprises reacting a centromeric clove with an alcohol and filtering the mixture to obtain a mixture thereof by decolorizing and concentrating the glycoside, Asian ticoside and a magicacosaide solution, and then crystallizing the glycoside mixture, Dissolving the glycoside asialicoside and the madecaside mixture in an alcohol and reacting the mixture with a strong base; neutralizing with a strong acid, followed by concentration and drying to obtain hydrolysates asialic acid and methacaric acid; And a step of mixing a cosmetic or a beverage with a combination of at least one of glycyrrhizic acid, asialicoside, madecassoside or hydrolysates, asialic acid and methacaric acid, to form a cosmetic composition or a beverage composition.
1) Extract of glycosides Asian ticoside and Madecasoside
Alcohols are added to the pulverized seedlings, which are then heated, stirred, filtered, decolorized with activated charcoal, and concentrated. The resulting solid is cooled, filtered and dried to obtain a mixture of glycoside, aspartic acid and madecaxone.
2) Crystallization of Asian ticoside sole material
The mixture of glycosides Asian ticoside and madecasoside was filtered, discolored, concentrated and crystallized, and the resulting solid was filtered and dried to obtain an Asian ticoside.
3) Crystallization of hydrolysates, asialic acid and methacaric acid
The mixture of Asian ticoside and madecasoides of glycosides is dissolved in alcohol and added with strong bases (NaOH, KOH, etc.) and adjusted to pH 5 ~ 7 with strong acid (HCl, H 2 SO 4 etc.) A solid of the madecanoic acid is produced.
4) Used for cosmetics and beverages of ginseng gypsum and hydrolyzate
The present invention provides a cosmetic composition having an effect of wound healing and cell regeneration by obtaining a mixture of an Asian ticoside and a madecasoide, a mixture of an Asian ticoside and a saccharide, and an Asian ticoside and a hydrolyzate of a centipede, By applying a mixture of two or more paper to a functional beverage, it can be used for skin improvement and skin disease prevention and treatment in daily life. This suggests that the conventional cosmetic composition is more effective than the moisturizing or wrinkle-improving application of centilla extracts. That is, 30 to 50% (w / w) of Asian ticoside was added to two kinds of mixtures containing 30 to 50% (w / w) of asialic acid and 30 to 50% (w / w) , Or a mixture of two kinds of asialicoside and madecassoside.
The content of the asialicoside and the madecosaide used in the present invention is 50% (w / w) or more, 50% (w / w) or more, respectively, (W / w) according to cosmetic creams, lotions, shampoos, soaps, functional beverages and the like used in the preparation of the composition.
The conventional cosmetic composition using a mixture of Asian ticoside alone or with an asialic acid shows only moisturizing effect and wrinkle-improving effect. However, the present invention can provide a cosmetic or beverage composition by adding madecaside, asialic acid or methacaric acid to the Asian ticoside to provide wound healing, cell regeneration and skin disease prevention effects.
1 is a manufacturing process diagram of the present invention.
In the present invention, Asian ticoside, madecaside, and asialic acid and methacaric acid to be used by the present invention were produced from the centellae by the following method.
<First step>: Asian Ticoside And Madecasso Side extraction.
1 kg of the dried centipede is pulverized, and 3 to 10 kg of ethanol is added at 3 to 10 kg (w / w) at 40 to 60 ° C, followed by agitation for 8 to 12 hours to extract the mixture of the Asian ticoside and the madecosaide. The extract was filtered, decolorized with activated charcoal, and then the ethanol was concentrated to 80%. The resulting solid was cooled to 24 to 26 ° C, filtered and dried to obtain 68 g of asialicoside and madecassoside. As the extraction solvent, in addition to ethanol, lower alcohol such as methanol, propanol, and butanol may be used.
<Second Step>: Asian Ticoside Single material crystallization
In the first step, the filtered filtrate was decolorized and concentrated to crystallize. The resulting solid was filtered and dried to obtain 30 g of Asian ticoside.
<Step 3>: Asian Acid Mountain Of Madeca crystallization
After dissolving 6 L of 70% (w / w) ethanol obtained in the first step and 120 mL of 20% NaOH as a hydrolyzing agent, stirring was carried out at 70-80 ° C for 3-4 hours, (W / w) HCl to adjust the pH to 5-7 and concentrate to remove the ethanol, resulting in the formation of asialic acid and methacaric acid. After filtration and drying, 41 g of a mixture of at least 80% (w / w) of asyric acid and methacaric acid was obtained. In this case, KOH may be used instead of NaOH as the hydrolyzing agent, and H 2 SO 4 may be used instead of HCl as a neutralizing agent.
< Asian Ticoside Analysis conditions>
After dissolving 20 mg of methanol in 50 ml of Asian ticoside and using a C18, 3.9 x 150 mm (Bondapak) column, the ratio of acetonitrile: methanol: water = 10: 40: In the squad, Asian ticoside and Madecaso side appear in 1.1 minutes.
< Asian Acid Mountain Of Madeca Analysis conditions>
Methanol (50 ml) was dissolved in 30 mg of the two components, and then a C8, 4.6 × 150 mm (Beckman) column was applied at a flow rate of 1.5 ml / min in a ratio of acetonitrile: methanol: water = 3: 3: , And peak of asialic acid appeared in 8.7 minutes. Asiatic acid was 40.2% and that of methacaric acid was 44.1%. The sum of both substances was 84.3%, which satisfied 50% (w / w) or more.
Thus, in the present invention, 41 g of the obtained mixture of asialic acid and methacaric acid and 30 g of Asian ticoside were mixed in the following proportions to prepare a composition to be added to the final cosmetic as shown in Table 1.
The three-component composition obtained from the present invention can be used in an amount of 0.01 to 10% (w / w) based on the total weight of cosmetic and functional beverages, preferably 0.2 to 0.5% (w / w). In addition, the centipede composition of the present invention (a mixture of Asian ticoside, madecasoside, asialic acid, and methacaric acid) can be used for wound healing medicines, intrinsic medicinal food additives and the like for oral use. Especially when it is added to beverages and so on, it is possible to cure the inner ear such as the stomach due to the wound healing function. Cosmetics can be widely used such as nutritional cream, softening longevity, skin adhesive patch, essence, nutritional gel, massage cream, pack, soap, water bottle, shampoo, etc. Especially when it is used for cosmetics, purified water, oil, surfactant , A moisturizing agent, a high alcohol, a pigment, a fatty acid, a chelating agent, an antiseptic, a wax, an antioxidant, a fragrance, a pH adjusting agent and the like.
Among the above excipients, as the oil component, mineral oil, cyclomethicone, squalane, octyldodecyl myristate, olive oil, macadamia nut oil, glyceryl octanoate, castor oil, ethylhexyl isononanoate, dimethicone, Pentasiloxane, sunflower seed oil and the like are used. Surfactants include, but are not limited to, sorbitan sesquiunorate, polysorbate 60, glyceryl stearate, prochymal glyceryl stearate, sorbitan oleate, sorbitan stearate, diai-cetyl phosphate, sorbitan stearate / Croscocite, glyceryl stearate / polyethylene glycol-100 stearate, cetearyl-6 olivate, arachidyl alcohol / behenyl alcohol / arachidyl glucoside. Polypropylene glycol-26-butes-26 / polyethylene glycol-40 hydrogenated castor oil and the like. As the moisturizing agent, glycerin, sorbitol, propylene glycol, butylene glycol, hexylene glycol, diglycerin, betaine, glycereth-26, methylglucose-20 and the like are used. As the higher alcohol, cetyl alcohol Stearyl alcohol, octyldodecanol, isostearyl alcohol and the like are used. Examples of thickening agents include xanthan gum, carbomer, magnesium aluminum silicate, cellulose gum and dextrin palmitate. Examples of the chelating agent include disodium, Tetra sodium dithiophosphate and the like are used. As the fatty acid, stearic acid, myristic acid, palmitic acid, isostearic acid, lauric acid and the like are used, and as the fatty acid, Examples of the preservative include methylparaben, butylparaben, propylparaben, phenoxyethanol, imidazolidinyl urea, chlorphenacin and the like as the preservative. As the wax, for example, Carnauba wax, beeswax, beeswax, etc. may be used. As the pH adjusting agent, triethanolamine, citric acid and the like may be used. As the fragrance, natural fragrance, combination fragrance and the like may be used.
Thus, in a preferred embodiment, the present invention relates to a cosmetic wrinkle containing the above composition. In a more preferred embodiment, the wrinkle-improving cosmetic product includes a nutritive cream, a convergent lotion, a soft lotion, an essence, a nutritional gel, and a massage cream.
The present invention also relates to a cosmetic composition for the purpose of additionally using madecasone or methacaric acid, which enhances wound healing and cell regeneration function, which is not solely or in combination with Asian ticoside and asialic acid of the existing patent in Table 2 do.
As described above, the present invention is also applicable to a mixture of asialic acid and methacaric acid, which can be obtained by hydrolysis of asialicoside and madecassoside.
These compounds, which are the components of the centipedes, are not toxic, and they are also sold as gastrointestinal drugs because of their ability to heal and regenerate cells. Since they can be developed as gastrointestinal diseases or other non-pharmaceutical beverages, Were used alone as shown in Table 2 to prepare health functional beverages.
When preparing a functional drink with the composition as shown in Table 2, it is aimed to enhance the function of the beverage composition by adding the components of the centilla extract 1, 2, 3, 4 or 5 to the generally applied beverage composition.
In general, sweeteners to be used in beverages include sardine glucose, maltose, fructose, stevioside isomer, honey, aspartame, acesulfame K and the like. Examples of the organic acid include citric acid, lactic acid, various fruit extracts, Natural ginseng extracts such as wood, dandelion, red ginseng, jujube, squid, and ginger are used. Gellan gum, guar gum, alginic acid sodium, CMC sodium and the like are used as the viscosity regulators, and sodium benzoate, P-metal benzoic acid, Propyl benzoic acid and the like can be used. D-sorbitol and xylitol can be used as polyhydric alcohols, citric acid, vitamin C, taurine, royal jelly and oligosaccharide can be added in various forms. To provide a health functional beverage.
< Example 1> Nourishing Cream 1
The mixture ratio of nutritional cream was 0.2% (w / w) of mixture of Asian ticoside and madecasoside as a centipede extract ingredient. The nutritional cream composition is composed of 6% w / w 1,3-butylene glycol, 46% w / w glycerin, 1.26% w / w mineral oil, 36% w / w polysorbate 60, Nutrition was performed using purified water of 56% (w / w) cetyl alcohol, 0.16% (w / w) propylparaben, benzophenone-9 26% (w / w), carboxyvinyl polymer 16% Cream.
< Example 2> Milk lotion
Mixing ratio of milk lotion in cosmetic ingredients was 0.2% (w / w) of mixture of Asian ticoside and didecanoic acid as herbal extract ingredients. The milk lotion composition contains propylene glycol 6% (w / w), mineral oil 4% (w / w), triethanolamine 1.2% (w / w), tocopheryl acetate 3% (w / 5% (w / w), allantoin 3% (w / w), macadamia nut oil 2% (w / w), polysorbate 20 1.5% (w / w), sorbitan sesquioleate 1% (w / w), 0.1% (w / w) propylparaben and 1% (w / w) lecithin.
< Example 3> Nutrition Cream 2
Among the cosmetics, the centipede extract of the nutritional cream was used as a mixture of 0.5% (w / w) of an Asian ticoside and a madecassoside. The composition of the nutritional cream is composed of 0.2% (w / w) alanantonin, 7% (w / w) 1,3-butylene glycol, 0.1% w / w tocopheryl acetate, 2.2% w / w stearic acid, (w / w), ceramide 2% (w / w), polysorbate-60 2% (w / w), sorbitan sesquioleate 2.5% (w / ), Carboxyvinyl polymer 1% (w / w), mineral oil 4% (w / w), vegetable oil 4% (w / w), sodium hyaluronate 0.5% (w / w / w) and the rest of the purified water.
< Example 4> Massage Cream
Among the cosmetics, 0.3% (w / w) of a mixture of Asian ticoside, asialic acid and methacaric acid was used as a centipede extract component of massage cream. The massage cream composition comprises at least one composition selected from the group consisting of: 6% w / w 1,3-butylene glycol, 4% w / w glycerin, 0.5% w / w triethanolamine, 0.1% w / w tocopheryl acetate, (W / w), 2% w / w cetearyl alcohol, 2% w / w alentonine, 2.1% w / w polysorbate-60, sorbitan sesquioleate 2.5 A massaging cream was prepared using purified water of% w / w, 0.1% w / w propylparaben, 1% w / w carboxyvinyl polymer, 0.2% w / w sodium hyaluronate, .
< Example 5> Cosmetics pack
Among the cosmetics, 0.2% (w / w) of a mixture of Asian ticoside and a madecasonic acid was used as a centipede extract component of the pack. The pack composition contained 3% w / w ethyl alcohol, 0.02% w / w EDTA-2Na, 5.1% w / w propylene glycol, 4.5% w / w glycerin, 1% w / w), 0.2% (w / w) of polyoxide, 0.2% (w / w) of sodium hyaluronate and the rest of purified water.
< Example 6> Body soap soap
Among the cosmetics, 0.2% (w / w) of a mixture of Asian ticoside, asialic acid, and methacaric acid was used as a soap extract for body soap. The body soap composition comprises 20% (w / w) of Coconut Oil, 30% (w / w) of Olive Oil, 20% (w / w) of Evening Oil, Palm Oil 4% w / w Avocado Oil 10% w / w NaOH 9% w / w purified water 6% w / w Other Spices 0.8 % (w / w) was used to make body soap.
< Example 7> Soap for scalp
Of the cosmetic products, the extract of the soap of the scalp was 0.5% (w / w) of a mixture of Asian ticoside, asialic acid and methacaric acid. The soap composition for the scalp is composed of 30% (w / w) of Coconut Oil, 30% (w / w) of Evening Oil, 10% (w / w) of Avocado Oil, Soaps were prepared using 20% (w / w) of Palm Oil, 4% (w / w) of Seaweed Extract and 0.4% (w / w) of other fragrances.
Example 8 Shampoo composition
Among the cosmetics, 0.5 g of a mixture of Asian ticoside and madecassoside was used as a centipede extract component of the shampoo composition. The shampoo composition was prepared by mixing 100 ml of purified water, 5 g of propylene glycol, 1 g of glycerin, 8 g of sodium lauryl sulfate, 5 g of cocamide dieye, 5 g of lauraamide dihey, 5 g of cocamidopropyl methacrylate, 0.5 g of tocopherol, 0.1 g of sodium citrate, g and fragrance dose were used to prepare the shampoo.
The centilla cicada extract used in the cosmetic composition is composed of composition 1 (a single ingredient of an Asian ticoside), a composition 2 (a mixture of an Asian ticoside and an asialic acid), a composition 3 (a mixture of an Asian ticoside and a madacalcoside) Mixture of acid and methacaric acid), Composition 5 (mixture of Asian ticoside and asialic acid, mixed with methacrolein) was used. In addition, cosmetic composition was tested for skin regeneration and wound healing satisfaction test, skin cell regeneration effect, wound healing effect, skin elasticity improvement effect test and wrinkle improvement effect by using components of nutritional cream blend ratio.
< Test Example 1>; Skin regeneration and wound healing satisfaction survey
Skin regeneration and wound healing satisfaction were investigated according to the blending ratio of the above compositions 1 to 5. 50 females and 60 males and females who received laser treatment and peeling treatment were applied to the right side of the same face and the left side of the same face to the treatment site, respectively. And applied twice a day (morning / evening) for 1 week. The degree of satisfaction with the degree of skin regeneration and wound healing improvement was examined and the results are shown in Table 3 below.
From the above results, it was found that Test Example 3 was very good at 50% and Test Example 4 was very good at 40%, while each control group was very good and not very good.
Therefore, the composition of the present invention is judged to have excellent skin regeneration and wound healing satisfaction.
< Test Example 2>; Regenerative effect of skin cells
In order to examine the skin regeneration effect through the proliferation of skin cells donated to human skin fibroblasts, analysis was performed using Cell counting kit-8. And cultured in Dulbecco's Modification of Eagle's Medium supplemented with 10% FBS (fetal bovine serum) and 1% penicillin-streptomycin at 37 ° C and 5% CO 2. 1,000 human dermal fibroblasts were plated in a 96-well plate, and the composition of Table 4 was each treated in a cell culture medium. After 72 hours, the degree of cell proliferation was confirmed. For the measurement, the CCK-8 solution was added to the cell culture medium (100 μl / well), incubated for 3 hours in an incubator, and absorbance was measured at 450 nm. The increase in the number of cells was investigated based on the results of the standard curve. The results are shown in Table 4 below.
From the above results, it can be seen that the composition of the present invention is superior to the control group in promoting skin regeneration. In particular, it can be seen that the composition 3 and the composition 4 have a skin regeneration promoting effect of 50% or more as compared with the dodo group.
< Test Example 3>; Wound healing effect
The inhibition of IL-6 expression in Human Epidermal Neonatal Keratinocyte Cells was confirmed by the real time-reverse transcription polymerase chain reaction (Q-RT-PCR). Human dermal keratinocytes were purchased from Lonza, Inc. (Walkersville, MD, USA). Cell culture media were subcultured in a CO 2 incubator (CO 2 incubator) at 37 ° C Cells were cultured under the condition of 5% CO 2. To a 500 ml KBM-2 (Clonetics CC-3103) medium was added a KGM-2 bullet kit (BPE: Bovine pituitary extract (2 ml) (hEGF: human epidermal growth factor: 0.5 mL), insulin (0.5 mL), hydrocortisone (0.5 mL), transferrin (0.5 mL), epinephrine (0.5 mL), gentamicin sulfate The human keratinocytes were filled with 70% of the surface of the cell culture plate and cultured in a medium supplemented with interferon-gamma (Glucomycin Suflate Amphofericin-B: GA-1000, 0.5 ml) 100 U / ml), and after 30 minutes, the compositions 1 to 5 of the present invention and the control group After 24 hours of treatment with each composition, the cells were treated with 10 ml of phosphate buffered saline, and the cells were incubated for 24 hours. (Trizol reagent, Invitrogen, Carlsbad, Calif., USA) to separate total RNA (total RNA). The isolated RNA was purified using RNA kit (Qiagen RNeasy kit, Qiagen, Valencia, CA CDNA was synthesized from the RNA isolated from the above using a reverse kit (Superscript Reverse Transcriptase (RT) II kit, Invitrogen, Carlsbad, Calif.), And the cDNA was synthesized by Q-RT-PCR The expression of IL-6 was quantitatively analyzed. The expression pattern of IL-6, an inflammation inducer, was evaluated using a TaqMan gene expression assay kit (Applied Biosystems, Foster City, Calif.). IL-6 gene expression analysis was performed using the non- The results are shown in Table 5 below. The inhibition rate is shown in Table 5, and the unit is%.
From the above results, it can be seen that the composition of the present invention is superior in the inflammatory reaction inhibitory effect as compared with the control group. In particular, it can be seen that composition 3 and composition 4 have a wound healing effect of 50% or more as compared with the dodo group. As described above, the composition of the present invention is applied as a wound dressing cosmetic or beverage because it has a clear effect compared with the control group from the results of skin regeneration and wound healing satisfaction test, skin cell regeneration test and wound healing effect test have.
< Test Example 4>; Skin elasticity improvement test
The effect of improving the skin elasticity of the control group without addition of the Asian ticoside ingredient in the preparation of the nutritional cream, milk lotion, massage cream and pack of the examples was measured through clinical studies. The skin elasticity improvement effect was evaluated by measuring changes in skin elasticity. Skin elasticity was measured in 40 healthy women in their twenties, twenties, thirties, and 40s who remained constant at 24 ~ 26 ℃ and humidity 38 ~ 40%. Nutritional cream, milk lotion, massage cream and pack were applied to the subject's face twice a day for 3 months, and then measured using Cutometer SEM 474. The results are shown in Table 6 below. The results are shown in Table 6. The results are shown in Table 6 below.
elasticity
From the above results, it can be seen that the composition of the present invention is superior to the control group in improving the skin wrinkle (elasticity) even when applied to cosmetics.
< Test Example 5>; Wrinkle improvement effect
The effect of improving the wrinkles of Example 1 (nutritional cream), Example 2 (milk lotion), Example 4 (massage cream), Example 5 (pack) and the control group was evaluated as follows.
Twenty women in their thirties and twenties were applied twice daily morning and evening for four weeks to the inside of the arm hump, and the state of the wrinkles was measured by an image analyzer Skin touch system (STS, Korea) . This value indicates the number of wrinkles is high and the number of wrinkles is six minutes. The higher the number, the more wrinkles.
Improving
From the above results, it can be seen that the composition of the present invention is superior to the control group in improving wrinkles even when applied to cosmetics.
< Example 9> Beverage composition
Five kinds of beverages were prepared using 0.2-0.6g of the centipede extract ingredients of the beverage composition as the following five cases. The composition used was 4 ml of honey, 2 ml of chito oligosaccharide, 1 g of sodium citrate, 1 g of sodium alginate, 1 g of D-sorbitol, 0.1 ml of ginseng, 0.5 ml of red ginseng concentrate, 0.2 g of vitamin C and purified water.
< Test Example 6>; Sensory test
According to the compounding ratio of the centilla extract (composition 1: 0.2, composition 2: 0.3, composition 4: 0.4, composition 5: 0.45), centilla's vitamin drink (K pharmaceutical product) , And palatability were compared. (5, good, 4, moderate; 3, insufficient; 2 points or less) on well-trained panels (20s, 30s, 2s in each 40s).
From the above results, it can be seen that the beverage composition using the Centella asiatica extract retains the same or similar range of taste even when the products are compared with the sensory properties.
The screen fold extract of the present invention provides moisturizing effect, wrinkle improvement, wound healing and anti-epileptic effect when it is used as a beverage or a cosmetic, so that it is industrially applicable.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150151106A KR20170050062A (en) | 2015-10-29 | 2015-10-29 | Composition for Beverage and Cosmetics Containing Asiaticoside Madecassoside Asiatic acid Madecasic acid Extracted from Centella Asiatica Manufacturing Method Thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150151106A KR20170050062A (en) | 2015-10-29 | 2015-10-29 | Composition for Beverage and Cosmetics Containing Asiaticoside Madecassoside Asiatic acid Madecasic acid Extracted from Centella Asiatica Manufacturing Method Thereof |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170075073A Division KR20170072177A (en) | 2017-06-14 | 2017-06-14 | Composition for Beverage and Cosmetics Containing Asiaticoside, Madecassoside, Asiatic acid & Madecasic acid Extracted from Centella Asiatica & Manufacturing Method Thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20170050062A true KR20170050062A (en) | 2017-05-11 |
Family
ID=58741028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020150151106A KR20170050062A (en) | 2015-10-29 | 2015-10-29 | Composition for Beverage and Cosmetics Containing Asiaticoside Madecassoside Asiatic acid Madecasic acid Extracted from Centella Asiatica Manufacturing Method Thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20170050062A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107739399A (en) * | 2017-11-29 | 2018-02-27 | 陶坤秀 | The extracting method of brahmic acid |
KR20200013920A (en) * | 2018-07-31 | 2020-02-10 | 주식회사 퓨어스킨 | Cosmetic composition for skin soothing containing complex extracts of Hamamelis virginiana, Centella asiatica and Boswellia serrata resin, and mask-pack comprising the same |
KR102096414B1 (en) * | 2020-02-03 | 2020-04-02 | 이원주 | Cosmetic composition for improving of acne skin |
WO2020111297A1 (en) * | 2018-11-28 | 2020-06-04 | (주)에스디생명공학 | Cosmetic composition comprising thyme composite extract as active ingredient for moisturizing skin |
KR20220014765A (en) * | 2020-07-29 | 2022-02-07 | 충청북도 (관리부서:충청북도 농업기술원) | Manufacturing method of beverage using the centella asiatica |
KR102485135B1 (en) * | 2022-09-13 | 2023-01-05 | 황의경 | A multi-fuctional cosmetic composition comprising astaxanthin complex |
KR102537252B1 (en) * | 2022-11-14 | 2023-05-26 | 안성규 | Anti-inflammatory composition for pet |
KR20240009322A (en) | 2022-07-13 | 2024-01-22 | 주식회사 현대바이오랜드 | An oil emulsion of a sparingly soluble pentacyclic triterpene compound isolated Centella asiatica and a cosmetic composition containing the same for skin regeneration, anti-inflammatory and skin irritation alleviation effects |
-
2015
- 2015-10-29 KR KR1020150151106A patent/KR20170050062A/en not_active Application Discontinuation
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107739399A (en) * | 2017-11-29 | 2018-02-27 | 陶坤秀 | The extracting method of brahmic acid |
CN107739399B (en) * | 2017-11-29 | 2020-05-05 | 陶坤秀 | Method for extracting madecassic acid |
KR20200013920A (en) * | 2018-07-31 | 2020-02-10 | 주식회사 퓨어스킨 | Cosmetic composition for skin soothing containing complex extracts of Hamamelis virginiana, Centella asiatica and Boswellia serrata resin, and mask-pack comprising the same |
WO2020111297A1 (en) * | 2018-11-28 | 2020-06-04 | (주)에스디생명공학 | Cosmetic composition comprising thyme composite extract as active ingredient for moisturizing skin |
CN112584820A (en) * | 2018-11-28 | 2021-03-30 | 株式会社Sd生命工学 | Cosmetic composition for skin moisture containing thyme complex extract as active ingredient |
KR102096414B1 (en) * | 2020-02-03 | 2020-04-02 | 이원주 | Cosmetic composition for improving of acne skin |
KR20220014765A (en) * | 2020-07-29 | 2022-02-07 | 충청북도 (관리부서:충청북도 농업기술원) | Manufacturing method of beverage using the centella asiatica |
KR20240009322A (en) | 2022-07-13 | 2024-01-22 | 주식회사 현대바이오랜드 | An oil emulsion of a sparingly soluble pentacyclic triterpene compound isolated Centella asiatica and a cosmetic composition containing the same for skin regeneration, anti-inflammatory and skin irritation alleviation effects |
KR102485135B1 (en) * | 2022-09-13 | 2023-01-05 | 황의경 | A multi-fuctional cosmetic composition comprising astaxanthin complex |
KR102537252B1 (en) * | 2022-11-14 | 2023-05-26 | 안성규 | Anti-inflammatory composition for pet |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101855095B1 (en) | Composition for enhancing whitening | |
KR20170050062A (en) | Composition for Beverage and Cosmetics Containing Asiaticoside Madecassoside Asiatic acid Madecasic acid Extracted from Centella Asiatica Manufacturing Method Thereof | |
KR20170072177A (en) | Composition for Beverage and Cosmetics Containing Asiaticoside, Madecassoside, Asiatic acid & Madecasic acid Extracted from Centella Asiatica & Manufacturing Method Thereof | |
KR101776071B1 (en) | Composition containing red sword bean extract for anti-aging and whitening | |
BRPI0808065B1 (en) | NEW COSMETIC AND / OR PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATIONS | |
KR101702389B1 (en) | Composition having effects of skin moisturizing, exfoliating, improving skin elasticity, inhibiting erythema, anti-wrinkle or improving skin photoaging comprising ionone or salt thereof | |
KR20160116800A (en) | Composition for moisturizing skin | |
KR101715294B1 (en) | Composition having effects of skin moisturizing, exfoliating, improving skin elasticity, inhibiting erythema, anti-wrinkle or improving skin photoaging comprising diosmin or salt thereof | |
KR20200005188A (en) | composition for preventing or treating of wound comprising Indirubin derivative compound | |
JP2004067590A (en) | Female sex hormone production promoter and skin preparation for external use containing the same | |
JP2010024222A (en) | Collagen production promoter, hyaluronic acid production promoter, and collagen production and hyaluronic acid production promoter | |
KR101668357B1 (en) | Composition for improving skin conditions and method for improving skin conditions using the same | |
CN116889529A (en) | A composition comprising Ganoderma extract for improving hair or scalp state | |
WO2015001891A1 (en) | Composition for promoting collagen production, for promoting elastin production, and/or for promoting keratinocyte migration, and usage therefor | |
KR102577528B1 (en) | Composition for improving skin | |
KR101993575B1 (en) | Composition comprising tetradecane as active ingredients for improving skin wrinkle, skin moisturizing or skin elasticity | |
KR101701502B1 (en) | Composition having effects of skin moisturizing, exfoliating, improving skin elasticity, inhibiting erythema, anti-wrinkle or improving skin photoaging comprising decanal or salt thereof | |
KR102683678B1 (en) | Composition for improving skin comprising 2-phloroeckol as an active ingredient | |
KR102675988B1 (en) | Composition for improving skin containing 3,3',4-tri-O-methylellagic acid as an active ingredient | |
KR102236417B1 (en) | A composition for preventing or treating inflammation comprising an extract of Ilex cornuta and uses thereof | |
KR20170138754A (en) | Composition having effects of skin moisturizing, exfoliating, improving skin elasticity, inhibiting erythema, anti-wrinkle or improving skin photoaging comprising cadaverin or salt thereof | |
KR20170025365A (en) | Composition for improving skin | |
KR20230076555A (en) | Composition for skin moisturizing or enhancing skin barrier containing the polysaccharide from the root of Camellia sinensis | |
KR101656322B1 (en) | Compositions for improving skin wrinkle or enhancing skin elasticity comprising gardenoside | |
KR20230008956A (en) | Composition for preventing or improving skin damage caused by fine dust containing Adenocaulon himalaicum Edgew. extract or neochlorogenic acid as an active ingredient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
J301 | Trial decision |
Free format text: TRIAL NUMBER: 2018101000285; TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20180122 Effective date: 20190111 |